Home › Geographic Atrophy › Tennessee
Geographic Atrophy clinical trials in Tennessee
4 studies for Geographic Atrophy are looking for participants at sites in Tennessee.
Cities in Tennessee
A Study in Adults With Geographic Atrophy
- Tennessee Retina, PC, Nashville
RecruitingPhase 2
Ages 60 and older · All sexes · Updated Sep 21, 2026 · NCT07606365A Study Investigating Subcutaneously Administered Pozelimab in Combination With Cemdisiran or Cemdisiran Alone in Adult Participants With Geographic Atrophy
- Tennessee Retina, PC, Nashville
- Vanderbilt Eye Institute, Nashville
RecruitingPhase 3
Ages 50 to 85 · All sexes · Updated Sep 18, 2026 · NCT06541704A Study to Optimize Subretinal Surgical Delivery and to Evaluate Safety and Activity of Opregen in Participants With Geographic Atrophy Secondary to Age-Related Macular Degeneration (GAlette); Adaptive Optics (AO) Retinal Imaging Substudy in Association With Study GR44251
- Tennessee Retina PC, Nashville
RecruitingPhase 2
Ages 50 and older · All sexes · Updated Sep 15, 2026 · NCT05626114Study to Evaluate Efficacy and Safety of ONL1204 in Patients With GA Associated With AMD
- Vanderbilt Eye Institute, Nashville
RecruitingPhase 2
Ages 55 and older · All sexes · Updated Sep 10, 2026 · NCT06659445From ClinicalTrials.gov, data retrieved Oct 5, 2026. Each study sets its own eligibility; the study team decides who can join.